JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chapin, E. M.
Right arrow Articles by Andrade, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapin, E. M.
Right arrow Articles by Andrade, R.

Vol. 297, Issue 1, 395-402, April 2001


A 5-HT7 Receptor-Mediated Depolarization in the Anterodorsal Thalamus. I. Pharmacological Characterization

Esther M. Chapin and Rodrigo Andrade

Departments of Psychiatry and Behavioral Neurosciences and Pharmacology, and the Cellular and Clinical Neurobiology Training Program, Wayne State University School of Medicine, Detroit, Michigan

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Little is currently known regarding the electrophysiological response elicited by 5-hydroxytryptamine-7 (5-HT7) receptor stimulation in the brain. Previous anatomical studies have shown that the anterior thalamus expresses a high density of 5-HT7 receptors. Therefore, we used whole-cell recording techniques in the in vitro brain slices to examine the effects of serotonin on neurons of the anterodorsal nucleus of the thalamus (ADn). Bath application of 5-HT induces a large membrane depolarization and inward current in neurons of the ADn. Since these cells expressed 5-HT7 receptor mRNA, as determined by single-cell reverse transcriptase-polymerase chain reaction, we pharmacologically characterized the 5-HT receptor mediating this response. We found that the 5-HT1 and 5-HT7 agonists 5-carboxamidotryptamine (5-CT) and 5-methoxytryptamine mimicked the response to 5-HT, whereas the 5-HT2 agonist 2,5-dimethoxy-4-iodoamphetamine did not. Consistent with the involvement of a 5-HT7 receptor, 5-CT was approximately 18 times more potent than 5-HT. Furthermore, administration of the 5-HT1A and 5-HT7 agonist 8-hydroxydipropylaminotetralin mimicked and antagonized the effect of serotonin, suggesting it acted as a partial agonist. To determine if either the 5-HT1 or 5-HT7 receptor mediated the 5-HT-induced inward current, we used antagonists. We found that the 5-HT7 ligands ritanserin, methylsergide, LSD, and mesulergine could inhibit the 5-HT-induced inward current, whereas the 5-HT1 antagonist cyanopindolol had no effect. The pA2 value determined for mesulergine closely approximated that expected for a 5-HT7 receptor. Finally, we found that bath application of the selective antagonist SB-269770 blocks the 5-HT-induced inward current. These results identify the receptor mediating the serotonin-induced membrane depolarization in the ADn as the 5-HT7 subtype.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The effects of serotonin (5-hydroxytryptamine, 5-HT) in the central nervous system are mediated by multiple serotonin receptors. There are currently 14 receptor subtypes known, classified into seven receptor subfamilies based on their sequence homology, pharmacology, and signal transduction cascade (Hoyer et al., 1994). During the last two decades, there has been a growing understanding of the electrophysiological response mediated by many of these different receptor subtypes (Andrade, 1998; Barnes and Sharp, 1999). However, this understanding is still incomplete. There are receptor subtypes that have no identified electrophysiological function, and there are also well characterized physiological responses to 5-HT to which no known receptor can be assigned. Outstanding among the first of these is the 5-HT7 receptor subtype, a subtype that is well characterized from a pharmacological standpoint, but poorly characterized in terms of in situ electrophysiology in the brain.

The 5-HT7 receptor was originally cloned from several mammalian species, including rat (Lovenberg et al., 1993; Meyerhof et al., 1993; Ruat et al., 1993; Shen et al., 1993), mouse (Plassat et al., 1993), guinea pig (Tsou et al., 1994), and human (Bard et al., 1993), based on its homology to other serotonin receptors. As determined from sequence analysis, this serotonin receptor is part of the G-protein superfamily of receptors containing the typical seven transmembrane regions (Lovenberg et al., 1993; Meyerhof et al., 1993; Plassat et al., 1993; Shen et al., 1993; Tsou et al., 1994; Stam et al., 1997). In heterologous expression systems, the 5-HT7 receptor increases cAMP accumulation when stimulated by 5-HT (Meyerhof et al., 1993; Plassat et al., 1993; Shen et al., 1993; Tsou et al., 1994; Stam et al., 1997) and hence is thought to couple to Galpha s.

The 5-HT7 receptor pharmacology has been extensively studied in heterologous expression systems. In such systems, the 5-HT7 receptor can be stimulated with 5-HT as well as 5-HT1 agonists. For example, the rank order of potency at this receptor for several commonly used serotonin agonists is 5-carboxamidotryptamine (5-CT) > 5-HT congruent  5-methoxytryptamine (5-MeOT) > 8-hydroxydipropylaminotetralin (8-OHDPAT) 2,5-dimethoxy-4-iodoamphetamine (DOI) (Lovenberg et al., 1993; Plassat et al., 1993; Ruat et al., 1993; Hoyer et al., 1994; Adham et al., 1998). Conversely, many compounds traditionally considered 5-HT2 antagonists, such as ritanserin, methysergide, or mesulergine, are effective 5-HT7 antagonists (Bard et al., 1993; Lovenberg et al., 1993; Shen et al., 1993). Thus, the 5-HT7 receptor can be characterized broadly as a receptor activated by "5-HT1 " agonists, but inhibited by "5-HT2 " antagonists. This distinct pharmacological profile suggests a viable strategy for identifying 5-HT7 receptor-mediated responses in the central nervous system. Additionally, the recently available antagonist SB-269770 can be used to further characterize a 5-HT7-mediated response (Lovell et al., 1999; Bacon and Beck, 2000).

The distribution of 5-HT7 receptors in the central nervous system has been determined using in situ hybridization and receptor autoradiography using tritiated 5-CT. In both the guinea pig and the rat, there is a comparable distribution between the 5-HT7 mRNA determined by these assays (To et al., 1995; Gustafson et al., 1996; Heidmann et al., 1998). 5-HT7 receptors are widely expressed in the brain, with their highest expression levels being found in the anterior, paraventricular, and rhomboid nuclei of the thalamus and the CA3 region of the hippocampus (Gustafson et al., 1995; To et al., 1995).

In summary, the 5-HT7 receptor is positively linked to adenylate cyclase, is abundantly expressed in limbic regions, and displays a distinct pharmacological profile. Yet, despite these defining characteristics, its functional role in the brain remains poorly understood. Therefore, we used whole-cell patch clamp recording to examine the effect of 5-HT in the anterior thalamus, a region where 5-HT7 receptors are abundantly expressed. In the anterodorsal nucleus of the thalamus (ADn), we found that 5-HT induces a membrane depolarization and associated inward current and that this current is signaled by stimulation of 5-HT7 receptors. These results identify a physiological response elicited by the activation of 5-HT7 receptors in the thalamus.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Preparation of Brain Slices. Male Sprague-Dawley rats (p28-p42) were anesthetized with halothane and then decapitated. The brain was removed and placed in ice-cold Ringer's solution (composition in mM: 119 NaCl, 2.5 KCl, 1.3 MgSO4, 2.5 CaCl2, 1 NaH2PO4, 26.6 NaHCO3, and 11 glucose) bubbled to equilibrium with 95% O2/5% CO2. The cerebellum and the anterior forebrain were removed while the rest of the brain was affixed to a stage with cyanoacrylate glue. A vibratome was used to cut 400 µm thick brain slices containing the anterior thalamus. These slices were placed into a submerged chamber (Sakmann and Stuart, 1995) containing constantly bubbled Ringer's solution and left to recover for at least 1 h at room temperature. When recording, the slices were placed in a recording chamber (Nicoll and Alger, 1981) where they were held submerged between two nylon nets and continuously perfused (1-2 ml/min) with normal Ringer's solution bubbled with 95% O2/5% CO2 at 30°C.

Electrophysiological Recordings. Whole-cell recordings were obtained from the anterodorsal (ADn) and anteroventral thalamic nuclei using the "blind" tight-seal patch clamp recording technique (Blanton et al., 1989). The thalamic nuclei were identified using visual landmarks, specifically the stria medullaris and the 4th ventricle. A Flaming/Brown horizontal puller was used to make recording pipettes from borosilicate glass, o.d. 1.2 mm (Sutter Instrument Co., Novato, CA). The pipettes were filled with either a potassium gluconate solution (composition in mM: 115 potassium gluconate, 5 NaCl, 10 HEPES, 10 EGTA, 2 MgCl2, 1 CaCl2, 5 ATP, 0.5 GTP) or a cesium gluconate solution (composition in mM: 100 CsOH, 100 D-gluconic acid, 5 NaCl, 10 HEPES, 10 BAPTA, 1 MgCl2, 4 CaCl2, 5 ATP, and 0.5 GTP. The pH of these solutions was adjusted to 7.3 or 7.4 with KOH or CsOH, respectively.

An Axoclamp 2B amplifier (Axon Instruments, Foster City, CA) was used to measure voltages and inject current. Electrical signals were recorded with a paper chart recorder (model 3300, Gould Instruments, Valley View, OH). Voltage clamp experiments were done using the continuous voltage clamp mode of the amplifier. Uncompensated series resistance was always less than 30 MOmega and was compensated by greater than 70%.

Drugs were applied by dissolving the drugs at known concentrations in the Ringer's solution perfusing into the bath. Where indicated, slices were incubated with antagonists in the recovery chamber for greater than an hour to ensure equilibrium of the drug at the receptor site. Most drugs were obtained from Sigma (St. Louis, MO). Mesulergine and methylsergide maleate were gifts from the Sandoz Research Institute (East Hanover, NJ), ritanserin was a gift from Janssen Pharmaceutica (Beerse, Belgium), and SB-269770 was a gift from SmithKline Beecham (Philadelphia, PA).

Data Analysis. Data were analyzed using Origin (Microcal Software, Northampton, MA). The equation used to describe the dose-response relationship was y = A1 + (A2 - A1)/1 + e(x - x0)/dx, where dx is the Hill slope, A1 and A2 are the minimum and maximum inward current, respectively, and x is the effective concentration (EC50). Except where indicated, data are presented as means ± S.E.M. The pA2 value for mesulergine was estimated using the following equation.
<UP>pA<SUB>2</SUB></UP>=<UP>−log</UP><FR><NU>[<UP>antagonist</UP>]</NU><DE>[(<UP>A</UP>′/<UP>A</UP>)−1]</DE></FR>
where A and A' are equieffective agonist concentrations in the absence and presence of antagonists, respectively.

Reverse Transcriptase (RT)-Polymerase Chain Reaction (PCR). The brain was removed as described previously and then manually dissected to obtain the anterior thalamic nuclei for RNA isolation. RNASTAT 60 (Tel-Test, Friendswood, TX) was used to extract RNA from the tissue according to the manufacturer's instructions. For single-cell RT-PCR, whole-cell patch clamp was obtained by the blind tight-seal technique and the cell's contents were removed by suction. The electrode tip was then broken in a tube and the contents of the electrode expelled. The tube was placed on dry ice until the RT reaction was started. The cDNA was synthesized with 20 units of avian myeloblastosis virus reverse transcriptase, 10 mM Tris, 50 mM KCl (Roche Molecular Biochemicals, Indianapolis, IN and Promega, Madison, WI), 4 µg of random hexanucleotide primers, 1 mM dNTPs, 50 units of RNase inhibitor, and sterile water to make approximately 20 to 32 µl of reaction mix. The reaction was left at 25°C for 10 min, placed at 42°C for 60 min, and then placed at 99°C for 5 min. The cDNA from the 5-HT7 receptor was amplified using the following primer pairs: 5'-GAATATCAACCGGAAGCTCTC (sense primer A); 5'-CTGGATCATGTATCATGACCC (anti-sense primer A') (Heidmann et al., 1997); and 5'-GTGGACTTGTGGAAAGCACC (anti-sense primer C'). These two primer pairs should yield products of 132 bp for A to A' and 451 bp for A to C'. The PCR reaction was performed in a Perkin-Elmer GeneAmp PCR System 2400 (30-40 cycles of 95°C for 1 min, 60°C for 40 s, and 72°C for 1 min). The amplification of both primer pairs was done in 10 mM Tris/HCl, 50 mM KCl, 1.5 to 2.5 mM MgCl2, 200 µM dNTP mix, 40 nmol of each primer at pH 8.3 with 5 units of Taq DNA polymerase (Roche Molecular Biochemicals/Fisher Biotech, Pittsburgh. PA). Restriction analysis was done using AvaI and SphI (New England BioLabs, Beverly, MA) according to the manufacturer's instructions.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effect of Serotonin in the Anterior Thalamus. To locate a serotonin response mediated by 5-HT7 receptors, we focused on the anterior thalamus, a region where these receptors are abundantly expressed (Gustafson et al., 1995; To et al., 1995). Bath application of 5-HT (1-100 µM) elicited a membrane depolarization (Fig. 1) or inward current (Fig. 2) in the vast majority of neurons of the ADn (121 of 123 cells tested). In contrast, comparable administration of serotonin to cells of the anterior ventral thalamic nucleus resulted in less consistent results; cells exhibited either no effect, a small hyperpolarization, or a small depolarization (n = 10 cells tested). Accordingly, all experiments outlined in this paper were conducted on cells of the ADn.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of serotonin in the ADn. Bath application of serotonin elicits a concentration-dependent slow membrane depolarization in a cell of the ADn. The cell resting membrane potential was -61 mV.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2.   Serotonin induces a concentration-dependent inward current in the ADn. A, current traces illustrating the inward currents elicited by increasing concentrations of serotonin in a representative cell of the ADn. B, plot of the peak 5-HT-induced inward current for the cell illustrated in A. Vh = -60 mV, Iholding = 10 pA.

The mean depolarization in the ADn elicited by 10 to 30 µM serotonin was 10 ± 1.2 mV (n = 11 cells) that corresponded to an inward current of 89.3 ± 7.2 pA at -60 mV (n = 50 cells). No obvious desensitization was observed for this depolarization over repeated serotonin applications. Serotonin still elicited a depolarization and inward current when recordings were obtained using a cesium-based intracellular solution. Since the cesium-based intracellular solutions affords better voltage clamping conditions, all experiments aimed at identifying the receptor mediating this current were done in this solution.

The ability of serotonin to induce a depolarization and inward current in the ADn was concentration-dependent in the range of 300 nM to 100 µM. Figures 1 and 2 illustrate representative voltage and current traces from cells recorded in either current clamp or voltage clamp where increasing concentrations of serotonin induced increasing amplitudes of depolarization and inward current, respectively. The threshold for the 5-HT induction of the inward current was in the high nanomolar range, and the EC50 was 1.7 ± 0.2 µM (n = 5 cells).

Single-Cell RT-PCR Analysis. Previous in situ studies have located 5-HT7 receptor mRNA in the ADn, but they have not identified the cell types that expressed it (Lovenberg et al., 1993; Gustafson et al., 1995; To et al., 1995). These studies have generally assumed that neurons are the source of the 5-HT7 message, but this has not been directly investigated. Furthermore, there is evidence that thalamic glia express 5-HT7 receptor mRNA (Hirst et al., 1997). If 5-HT7 receptors play a role in mediating the depolarization we observed in the ADn, then 5-HT7 receptor mRNA must be expressed in the neurons of this nucleus. Therefore, we first tested this possibility by using single-cell RT-PCR techniques. In four separate trials, we recorded from single cells in the ADn and extracted the contents of these cells by suction, obtaining the mRNA. We next performed RT-PCR to amplify 5-HT7 mRNA using primers chosen to amplify across an intron to eliminate contamination by genomic DNA (Fig. 3A). Figure 3, B and C, depicts results from one of nine cells in which this experiment was successful. Administration of serotonin to this cell resulted in the characteristic inward current described previously (Fig. 3B). Subsequent amplification of this cell's contents using primers A and A' resulted in a band of approximately 135-bp long, consistent with the prediction for amplification of 5-HT7 receptor mRNA. In two additional cells, we obtained similar results when using primers A + C and A + A' in nested PCR reactions.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   Single-cell RT-PCR analysis of 5-HT7 mRNA in the ADn. A, diagram of the genomic organization of the 5-HT7 receptor gene and the position of the primers used in the present experiments (redrawn after Heidmann et al., 1997). Black lines indicate exons and gray lines indicate introns. Arrows denote the approximate positions for the primers. B, inward current elicited by 5-HT in a cell of the ADn. C, agarose gel electrophoresis of the PCR products amplified using selective 5-HT7 primers (A and A') from a 5-HT7 receptor plasmid (plasmid lane), the product of an RT reaction for material "harvested" from the extracellular space in the slice (slice lane), and cDNA from the cell in B (cell lane). The right lane depicts 100-bp ladder.

We performed a number of controls to confirm that the RT-PCR procedure detected 5-HT7 mRNA from the recorded cell. We obtained a band of the same size when we amplified from a 5-HT7 receptor containing plasmid or an RT-PCR reaction derived from anterior thalamic tissue (n = 3). Furthermore, digestion of the PCR product with AvaI or SphI resulted in two fragments of the predicted length for amplification of 5-HT7 receptor message (not shown). Since in these experiments we used the blind tight-seal technique, it was also possible that we may have acquired mRNA from the extracellular space. To test for this possibility, we inserted the electrode into the ADn to a point where we would normally obtain a cell and applied suction. We performed this control in parallel with obtaining neuronal mRNA in three of the trials. We were never able to amplify 5-HT7 mRNA from the electrode contents using this procedure (Fig. 3A, n = 3 attempts), suggesting that the mRNA that we amplified was from the cells recorded. These results supported the idea that neurons of the ADn express 5-HT7 receptor mRNA.

Identification of the 5-HT Receptor That Signals the Membrane Depolarization in the ADn. Although our single-cell RT-PCR experiments indicated that the 5-HT7 mRNA is produced in the cells from which we record, this did not prove the receptor mediating the membrane depolarization was of the 5-HT7 subtype. In fact, previous in situ hybridization studies have detected expression of mRNA for several distinct serotonin receptor subtypes, including the 5-HT1A, 5-HT2A, and 5-HT2C receptors, over the ADn (Gustafson et al., 1995; To et al., 1995; Wright et al., 1995). Therefore, to identify whether the 5-HT7 receptor subtype was indeed the receptor responsible for the depolarization, we took advantage of the distinct pharmacological profile of 5-HT7 receptors. This analysis was possible because the 5-HT-induced inward current was reproducible, concentration-dependent, and non-desensitizing.

Previous studies have shown tryptamine analogs generally thought as 5-HT1 agonists, such as 5-CT and 5-MeOT, are effective agonists at 5-HT7 receptors (Hoyer et al., 1994; Saxena et al., 1998), whereas other compounds, such as DOI, are potent and selective 5-HT2 receptor agonists, but have negligible affinity for the 5-HT7 receptor (Hoyer et al., 1994). Therefore, as a first approach to the identification of the receptor mediating the serotonin-induced depolarization in the ADn, we compared these different agonists. As illustrated in Fig. 4, 5-CT (100 nM-3 µM, n = 22 cells) and 5-MeOT (10 µM, n = 8 cells) mimicked 5-HT and elicited an inward current, whereas DOI (30 µM, n = 3 cells) failed to mimic this effect of serotonin. 5-HT and 5-CT can activate a number of receptors, but their relative affinities for different serotonin receptor subtypes vary (e.g., Hoyer et al., 1994). Hence, the 5-CT to 5-HT potency ratio can serve as a useful index for serotonin receptor subtype identification in functional assays. Thus, we next compared the potencies of 5-HT and 5-CT for eliciting the inward current in the ADn. As illustrated in Fig. 5, the EC50 of 5-CT was 91 ± 18 nM, whereas that for serotonin was 1.7 ± 0.2 µM (see above). In other words, 5-CT is approximately 18-fold more potent than 5-HT in eliciting the inward current in the ADn. The rank order of potency determined by these experiments, 5-CT > 5-HT DOI, and the estimated 5-CT/5-HT potency is consistent with the involvement of a 5-HT7 receptor in this response.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of serotonergic agonists in the ADn. A, in three cells of the ADn, bath administration of 5-HT, 5-CT, and 5-MeOT induce similar inward currents. B, in contrast, bath administration of DOI was without effect, although the same cell responded to serotonin. C, administration of 8-OHDPAT elicits a small inward current and inhibits the effect of serotonin. The reduction in the response to serotonin was surmountable by the administration of a 10-fold higher concentration of 5-HT. Vh was -60 mV for all cells, Iholding ranged from 40 pA to 20 pA. All calibration bars depict 25 pA and 100 s.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Concentration-response curve for serotonin and 5-CT. In voltage clamp mode (Vh approx  60 mV), bath application of increasing concentrations of 5-HT induced progressively larger inward currents (n = 5 cells). The maximum current observed for serotonin at each concentration was used to fit the data to an occupational model for each cell (see Methods). This model estimated the maximal effect of serotonin at that cell, and this value was used to normalize the data. Because of the slow recovery from 5-CT, a single concentration of 5-CT was tested per cell, and the resulting values were normalized with respect to the mean response observed with a maximal concentration of 5-CT (3 µM). 5-CT was approximately 18 times more potent than 5-HT at eliciting an inward current in the ADn. The values next to each point in the curve for 5-CT indicate the number of cells tested at that concentration.

One of the more surprising, and defining, characteristics of the 5-HT7 receptor is its sensitivity to 8-OHDPAT. Although this compound is generally thought to be a highly selective 5-HT1A agonist, it also exhibits reasonable affinity for 5-HT7 receptors (Hoyer et al., 1994). Therefore, we next examined the effects of this compound in the ADn. Bath administration of a presumably maximal concentration of 8-OHDPAT (100-300 µM) produced a small inward current (approximately 20% of the maximal serotonin induced) and also antagonized the effect of serotonin (3-10 µM, n = 5 cells tested). Figure 4C illustrates a particularly clear example of the agonist activity of 8-OHDPAT. The ability of this compound to both mimic and antagonize the effects of serotonin indicates that 8-OHDPAT functions as a weak partial agonist at the receptor mediating the inward current.

To refine further the receptor identification, we turned to antagonists. First, we tested methysergide and LSD, two compounds that can be expected to exhibit high affinity for 5-HT7 receptors. As illustrated in Fig. 6, administration of methysergide (10 µM, n = 2 cells) or LSD (1 µM, n = 2 cells) completely blocked the ability of serotonin (10 µM) to elicit the inward current. Next, we examined whether 5-HT antagonists can distinguish between the serotonin receptor subtypes. Specifically, we tested mesulergine and ritanserin, which are potent inhibitors of 5-HT7 receptor function, and cyanopindolol, which exhibits little or no affinity for 5-HT7 receptors but is a potent antagonist of 5-HT1 receptors (Hoyer et al., 1994). As illustrated in Fig. 5B, bath administration of mesulergine (3-10 µM) was able to completely block the 5-HT-induced depolarization (Fig. 6, n = 3 cells), whereas ritanserin (nominally 3 µM) reduced the 5-HT-induced inward current or depolarization (n = 3 cells, data not shown). These effects did not reflect an action on 5-HT2 receptors, since ketanserin at concentrations that should completely block 5-HT2 receptors (1-10 µM) only slightly inhibited the serotonin-induced inward current (approx 20%, n = 3 cells tested, data not shown). In contrast to the effects of mesulergine and ritanserin, bath administration of the 5-HT1 selective antagonist cyanopindolol (10 µM) failed to reduce the inward current elicited by 3 µM serotonin (Fig. 6A, n = 5 cells). This lack of effect did not simply reflect failure of the antagonist to reach the receptors in the slice, because parallel applications of cyanopindolol to hippocampal slices blocked the 5-HT1A receptor-mediated outward current (n = 2 cells tested, data not shown).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Antagonism of the serotonin-induced inward current in the ADn. A, bath administration of cyanopindolol (Cy) had no detectable effect on the ability of serotonin to induce an inward current. B through D, in contrast, administration of mesulergine, methysergide, or LSD antagonized this effect of serotonin. Vh was -60 mV for all cells; Iholding ranged from -30 pA to no holding current. All calibration bars depict 25 pA and 100 s.

These qualitative results obtained with antagonists greatly narrowed the possible receptor subtypes that could mediate the serotonin-induced inward current in the ADn. The overall pharmacological profile clearly ruled out the possible involvement of receptors of the 5-HT2, 5-HT3, and 5-HT4 subtypes. In addition, the ability of mesulergine, and to a lesser extent ritanserin, to antagonize the effect of serotonin strongly argued against the involvement of receptors of the 5-HT5 and 5-HT6 subtypes. Finally, the failure of cyanopindolol to antagonize the effects of serotonin argues strongly against the involvement of 5-HT1 receptors. However, given that 5-HT pharmacology is complex, qualitative antagonist data alone cannot provide an unambiguous receptor identification. Therefore, we sought to strengthen the pharmacological identification of the receptor using a quantitative approach.

We focused on mesulergine and cyanopindolol, the two more selective compounds examined above. If, as suggested by the above results, 5-HT7 receptor stimulation was responsible for the inward current, then we would expect that mesulergine should shift the concentration-response curve for 5-HT with a potency in the low- to mid-nanomolar range, whereas cyanopindolol should exhibit no detectable affinity. As illustrated in Fig. 7, this is precisely what we found. Thus, when we obtained a 5-HT concentration-response relationship in the presence of mesulergine (100 nM), this antagonist was able to shift the concentration-response curve to the right by 5.6 times, to yield an EC50 value of 9.6 ± 1.2 µM. Using this data, we were able to estimate the affinity of mesulergine for the receptor mediating the inward current. This value (the pA2 value) was 31 nM, which is close to the affinity for mesulergine at the 5-HT7 receptor (20-75 nM; Lovenberg et al., 1993; Shen et al., 1993). In contrast, no detectable change in the concentration-response relationship for serotonin was detectable in the presence of 10 µM cyanopindolol. In fact, as shown in Fig. 7, the EC50 for serotonin estimated in the presence of cyanopindolol (2.0 ± 0.4 µM) was not significantly different compared with control experiments (p = 0.87, t test).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Concentration-response curve for serotonin in the presence of mesulergine or cyanopindolol. Mesulergine, but not cyanopindolol, elicited a shift in the concentration-response curve for serotonin. The EC50 for serotonin was 1.7 µM (black-square, n = 5 cells, data redrawn from Fig. 5 for illustration purposes). The EC50 for serotonin in the presence of mesulergine was 9.6 µM (, 100 nM, n = 3 cells), indicating a pA2 value of 31 nM. The EC50 for serotonin in the presence of cyanopindolol (, 10 µM, n = 3 cells) was 2.0 µM and was not different from that seen under control conditions.

During the late stages of this work, we were able to obtain a small sample of the new selective 5-HT7 receptor antagonist, SB-269770 (Lovell et al., 2000). This recently developed compound is more than 250-fold selective for the 5-HT7 receptor vis-à-vis most other 5-HT receptor subtypes, with the only exception being its limited selectivity (approximately 50-fold) for the 5-HT5A subtype. In the present experiments, and consistent with the results outlined above, SB-269770 was found to be a potent antagonist of the 5-HT-induced inward current (Fig. 8A). In a group of four cells tested, bath administration of SB-269770 (1-3 µM) resulted in a 89 ± 0.05% inhibition of the 5-HT-induced inward current (Fig. 8B). These results strengthen the pharmacological identification of the receptor mediating the inward current in the ADn as belonging to the 5-HT7 subtype.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 8.   SB-269770 antagonizes the 5-HT-induced inward current. A, bath administration of the selective 5-HT7 antagonist SB-269770 (1-3 µM) antagonized the 5-HT-induced inward current. B, summary of four cells tested, indicating the inhibition of 5-HT-induced inward current in the presence of SB-260770.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In this study, we have examined the possible involvement of 5-HT7 receptors in mediating the electrophysiological effects of serotonin in the anterior thalamus. We report that neurons of the ADn express 5-HT7 receptor mRNA as determined by single-cell RT-PCR and respond to serotonin administration with a depolarization or inward current. Based on a pharmacological analysis using selective agonists and antagonists, we conclude that this depolarization/inward current is signaled by activation of receptors of the 5-HT7 subtype.

Single-Cell RT-PCR Analysis. Administration of serotonin elicited a membrane depolarization or inward current in the vast majority of ADn neurons examined in this study. As a first step to examine the involvement of 5-HT7 receptors in this response, we tested for the expression of 5-HT7 mRNA in these neurons. This was an important first step because previous studies have reported the expression of 5-HT7 receptor-mediated responses in glial cells of the thalamus (Hirst et al., 1997). This raised the possibility that the 5-HT7 receptor expression detected by in situ hybridization and receptor autoradiography (Gustafson et al., 1995; To et al., 1995) in this brain region may be non-neuronal. We used primers selective for the 5-HT7 receptor to amplify cDNA obtained from RT reactions of mRNA from single cells of the ADn from which we recorded. We found that neurons that respond to bath application of 5-HT also express mRNA for the 5-HT7 receptor. This observation was consistent with the possibility that this receptor may mediate the 5-HT-induced response. However, by in situ hybridization, several other serotonergic receptors appear to be expressed in the ADn as well, including those of the 5-HT1A, the 5-HT2A, and 5-HT2C subtypes (Wright et al., 1995). This heterogeneity in serotonin receptor subtype expression led us to conduct a pharmacological analysis of the receptor mediating the 5-HT-induced depolarization and inward current in the ADn.

Pharmacological Analysis. To identify the receptor subtype involved in signaling the serotonin inward current in this area, we first tested a variety of agonists. The 5-HT-induced depolarization/inward current was concentration-dependent and mimicked by 5-CT, which was approximately 10 to 20 times more potent than 5-HT. 8-OHDPAT functioned as a low intrinsic activity partial agonist, whereas DOI was without a detectable effect on these cells. We complemented these results by examining receptor subtype-selective antagonists. We found that mesulergine, methysergide, LSD, and SB-269770 blocked the 5-HT-induced inward current whereas cyanopindolol did not. Additionally, low micromolar concentrations of ritanserin, but not ketanserin, inhibited the response. Finally, we compared the affinities of mesulergine and cyanopindolol at the receptor mediating the inward current. Mesulergine competitively antagonized the response of serotonin with an apparent affinity (pA2) of 31 nM, whereas cyanopindolol was found to have no detectable affinity for the receptor involved.

The results of this pharmacological analysis allow us to identify the receptor signaling the serotonin-induced depolarization in the ADn. This receptor displays a rank order of agonist potency such that 5-CT > 5-HT > 8-OHDPAT, is relatively insensitive to ketanserin, and is insensitive to cyanopindolol (Lovenberg et al., 1993; Ruat et al., 1993; Hoyer et al., 1994; Saxena et al., 1998). This profile is inconsistent with receptors of the 5-HT1, 5-HT2, 5-HT3, and 5-HT4 subtypes (Hoyer et al., 1994). Among 5-HT1 receptors, only the 5-HT1A receptor is sensitive to 8-OHDPAT, and this receptor subtype is potently antagonized by cyanopindolol. Therefore, the receptor involved is not of the 5-HT1 subtype. Similarly, the absence of effect of DOI and the inability of ketanserin to block the 5-HT-mediated response indicate that the 5-HT-induced depolarization is not mediated by a 5-HT2 receptor (Hoyer et al., 1994). Finally, the sensitivity of this receptor to 5-CT, as well as 8-OHDPAT, is inconsistent with the involvement of 5-HT3 or 5-HT4 receptors in this response.

From the discussion above, it is clear that the receptor involved must belong to the 5-HT5, 5-HT6, or 5-HT7 subtypes, or represent a novel serotonin receptor. The high affinity of this receptor for 5-CT vis-à-vis serotonin, its sensitivity to 8-OHDPAT, and its high affinity for mesulergine make it extremely unlikely that it belongs to the 5-HT6 subtype (Hoyer et al., 1994). Similarly, the nanomolar affinity of this receptor for mesulergine makes it also unlikely that it could belong to the 5-HT5A or 5-HT5B subtypes (Hoyer et al., 1994). Finally, the reduction in the 5-HT-induced inward current in the presence of the 5-HT7 selective antagonist SB-269770 greatly reduced the possibility that the 5-HT5 or 5-HT6 receptors mediate the inward current (Lovell et al., 2000). Thus, among known serotonin receptor subtypes, only the 5-HT7 receptor exhibits a pharmacological profile compatible with that of the receptor signaling the depolarization and inward current in the ADn.

Admittedly, identification by exclusion is risky, not the least because of the potential existence of as yet unidentified receptors not specifically excluded by the analysis. However, the present results reveal a very close match between pharmacology of the receptor signaling the depolarization and inward current in the ADn and that of the 5-HT7 receptor. Most notably, shows a 5-CT/5-HT potency ratio and a mesulergine affinity that closely approximate that expected for a 5-HT7 receptor (Lovenberg et al., 1993; Saxena et al., 1998). Furthermore, and as expected for a 5-HT7 receptor, this receptor displays the unusual feature of being sensitive to 8-OHDPAT and SB-269770 (Hoyer et al., 1994; Lovell et al., 1999). Given our current knowledge of serotonin receptor subtypes, it seems very unlikely that an as-yet-undiscovered receptor could exist that would simultaneously match all of these features. Therefore, based on the combined results from the single-cell RT-PCR and the pharmacological analysis, we conclude that the serotonin receptor mediating the depolarization and inward current in the ADn belongs to the 5-HT7 subtype.

5-HT-Induced Depolarizations. Previous studies have shown that among G-protein coupled 5-HT receptors, both 5-HT2 and 5-HT4 receptors can mediate slow membrane depolarizations in central neurons (North and Uchimura, 1989; Andrade and Chaput, 1991). The present results indicate that 5-HT7 receptors now join these receptors in being capable of mediating membrane depolarizations in the central nervous system. Interestingly, it has been known for many years that an additional "orphan" serotonin receptor also mediates membrane depolarizations through a mechanism involving cAMP and up-regulation of the cation-nonselective current Ih. In a previous study in dorsal root ganglion neurons, it was suggested that this "orphan" receptor may belong 5-HT7 subtype, but other receptor subtypes could not be excluded (Cardenas et al., 1999). In the accompanying paper, we rigorously test this hypothesis. We find that the 5-HT7 receptor-mediated depolarization we have identified in the ADn is indeed mediated by Ih. These results identify a physiological function for 5-HT7 receptors in the brain.

    Acknowledgments

We thank Drs. M. J. Bannon, G. Kapatos, and the members of their laboratories for help with the single-cell PCR. We also thank Drs. A. Wa and S. Haj-Dahmane for helpful discussions.

    Footnotes

Accepted for publication December 20, 2000.

Received for publication September 14, 2000.

This work was supported by Grant MH43985 from the National Institute of Mental Health. This study was also supported in part by a research grant (Joe Young, Sr.) from the State of Michigan.

Send reprint requests to: Dr. Rodrigo Andrade, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 2309 Scott Hall, Detroit, MI 48201. E-mail: randrade{at}med.wayne.edu

    Abbreviations

5-HT, 5-hydroxytryptamine; 5-CT, 5-carboxamidotryptamine; 5-MeOT, 5-methoxytryptamine; 8-OHDPAT, 8-hydroxydipropylaminotetralin; DOI, 2,5-dimethoxy-4-iodoamphetamine; ADn, anterodorsal nucleus of the thalamus; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; RT-PCR, reverse transcriptase-polymerase chain reaction; LSD, lysergic acid diethylamide; bp, base pair; EC50, effective concentration of 50%.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/01/2971-0395-0402$03.00
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Cereb CortexHome page
C. Varela and S. M. Sherman
Differences in Response to Serotonergic Activation between First and Higher Order Thalamic Nuclei
Cereb Cortex, November 21, 2008; (2008) bhn208v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Z. Xiang, L. Wang, and S. T. Kitai
Modulation of Spontaneous Firing in Rat Subthalamic Neurons by 5-HT Receptor Subtypes
J Neurophysiol, March 1, 2005; 93(3): 1145 - 1157.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. P. Bengtson, D. J. Lee, and P. B. Osborne
Opposing Electrophysiological Actions of 5-HT on Noncholinergic and Cholinergic Neurons in the Rat Ventral Pallidum In Vitro
J Neurophysiol, July 1, 2004; 92(1): 433 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-C. Beique, B. Campbell, P. Perring, M. W. Hamblin, P. Walker, L. Mladenovic, and R. Andrade
Serotonergic Regulation of Membrane Potential in Developing Rat Prefrontal Cortex: Coordinated Expression of 5-Hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 Receptors
J. Neurosci., May 19, 2004; 24(20): 4807 - 4817.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J.-C. Beique, E. M. Chapin-Penick, L. Mladenovic, and R. Andrade
Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex
J. Physiol., May 1, 2004; 556(3): 739 - 754.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z.-w. Zhang
Serotonin Induces Tonic Firing in Layer V Pyramidal Neurons of Rat Prefrontal Cortex during Postnatal Development
J. Neurosci., April 15, 2003; 23(8): 3373 - 3384.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. E. Monckton and D. A. McCormick
Neuromodulatory Role of Serotonin in the Ferret Thalamus
J Neurophysiol, April 1, 2002; 87(4): 2124 - 2136.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Chapin and R. Andrade
A 5-HT7 Receptor-Mediated Depolarization in the Anterodorsal Thalamus. II. Involvement of the Hyperpolarization-Activated Current Ih
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 403 - 409.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chapin, E. M.
Right arrow Articles by Andrade, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapin, E. M.
Right arrow Articles by Andrade, R.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition